News & Analysis on Clinical Trial Services & Contract Research And Development
A new single-use bioproduction plant will bring in annual revenues of $40m, says Avid Bioservices which is already eyeing up additional capacity to cope with contract manufacturing demand.
Sanofi Pasteur says Mexican approval for Dengvaxia vindicates the ‘industrial risk’ it took when it invested €350m in a dengue fever vaccine plant in 2009.
Scientists have identified seaweed as a source of nutrients for the expansion of pluripotent stem cells needed for future drug testing.
DuPont and The Dow Chemical Company have ended speculation by announcing they are to merge and the combined company will be called DowDuPont.
WuXi PharmaTech and PRA Health Sciences have ended a three year clinical trial management partnership in China.